ARTHEx Biotech Advances ATX-01 for Myotonic Dystrophy
VALENCIA, Spain, May 27, 2026 ARTHEx Biotech, a clinical-stage biotechnology company focused on RNA-based therapeutics for neuromuscular diseases, has...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
VALENCIA, Spain, May 27, 2026 ARTHEx Biotech, a clinical-stage biotechnology company focused on RNA-based therapeutics for neuromuscular diseases, has...
SAN DIEGO, Calif., February 26, 2026 Avidity Biosciences, Inc. (Nasdaq: RNA) announced that it will present one oral and...
